Alejandro Galindo - May 18, 2022 Form 4 Insider Report for MANNKIND CORP (MNKD)

Role
EVP Endocrine Business Unit
Signature
/s/ Alejandro Galindo
Stock symbol
MNKD
Transactions as of
May 18, 2022
Transactions value $
-$15,277
Form type
4
Date filed
5/20/2022, 08:00 PM
Previous filing
May 12, 2022
Next filing
Aug 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKD Common Stock, $.01 Par Value Tax liability -$15.3K -4.79K -0.62% $3.19 772K May 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units.